.: ENCITE Website :.: 21 Cage Chemicals, IT

01 EIBIR, AT
02 Erasmus MC, NL
03 King´s College London, UK
04 Weizmann Institute of Science, IL
05 Max-Planck Institut f. Neurologische Forschung, DE
06 Tel Aviv University, IL
07 Università di Torino, IT
08 Institute for Clinical and Experimental Medicine, CZ
09 University of Freiburg, DE
10 University of Mons-Hainaut, BE
11 University Paris Descartes, FR
12 Friedrich-Alexander University, DE
13 Leiden University Medical Center, NL
14 The University of Milano - Bicocca, IT
15 Radboud University Nijmegen Medical Centre, NL
16 Foundation for Applied Medical Research, ES
17 Institut Curie, FR
19 BioSpace, FR
20 Medres, DE
21 Cage Chemicals, IT
22 University of Navarra, ES
23 The Hebrew University of Jerusalem, IL
24 Westfälische Wilhelms-Universität Münster, DE
25 Katholieke Universiteit Leuven, BE
26 The Chancellor, Masters and Scholars of the University of Cambridge, UK
27 Agencia Estatal Consejo Superior de Investigaciones Cientificas, ES
28 Consorci Institut Català de Ciències Cardiovasculars, ES
29 Vrije Universiteit Medisch Centrum Amsterdam, NL
30 Universitätsspital Basel, CH
Partners area

not in use here

21 Cage Chemicals, IT

Role and Contribution

Cage Chemicals will design, synthesise and provide highly sensitive, targeted and responsive Gd-chelates and CEST agents including nanosized systems such as micelles and liposomes, to be used in WP2.1 and other WPs.

CAGE Chemicals

Staff

Ivan Menegotto
Camilla Cavallotti

Camilla Cavallotti

PhD. 1998 Degree in Industrial Chemistry. 2002 PhD in Chemical Sciences. 2002-2006 Postdoctoral research for Università di Torino and CIRCMSB collaborator in the synthesis of new and improved contrast agents. 2006-now CAGE Chemicals. Experience in organic synthesis and process chemistry with specific expertise in the design and synthesis of contrast agents.